Published on NYU Langone Medical Center (http://www.med.nyu.edu)

Home > Printer-friendly > Printer-friendly

Printer-friendly

Printer-friendly

Biosketch / Results /

Bernard A. Feigenbaum, M.D.

Clinical Assistant Professor;
Departments of Medicine (GIM Div Dir) [1] and Otolaryngology (Otolaryngology) [2]

Clinical Addresses

14 PENN PLAZA, 225 WEST 34TH STREET
SUITE 1005
NEW YORK, NY 10122
Handicap Access: yes
Phone: 212-967-2726
Fax: 866-903-3908
[4]

« Back to Results [9]

Medical Specialties

Pediatric Allergy & Immunology, Allergy & Immunology

Medical Expertise

Eczema/Atopic Dermatitis, Asthma, Allergy And Immunology, Chronic Cough, Eosinophilic Esophagitis, Allergic Rhinitis (Hayfever), Drug Allergy, Sinusitis, Food Allergy

Clinical Responsibilities

**New phone due to storm (646) 664-1099** Bernard A. Feigenbaum, MD, FACP, FAAAAI is Director of the NYU Adverse Drug Reaction and Desensitization Program, and Clinical Assistant Professor of Medicine and Otolaryngology. He has over fifteen years of clinical and teaching experience and is Board-Certified in Allergy & Immunology.

Dr. Feigenbaum serves as a Medical Expert Consultant for an office of the NY State Board for Professional Medical Conduct, and has served as an expert witness and/or consultant in federal or state actions in five states.

Dr. Feigenbaum is passionate about improving medical care, and is known for his friendly, caring manner and for his teaching skills. He has given presentations about Professionalism in Medicine for the American Board of Internal Medicine, and recently lectured at Memorial Sloan-Kettering, Hospital for Special Surgery, Hospital for Joint Diseases, NYU Langone Medical Center, and the NYC Department of Health.

Dr. Feigenbaum is a Principal Investigator at NYULMC, and his recent translational study of mycotoxins in chronic rhinosinusitis will be published in Otolaryngology-Head and Neck Surgery. Research interests include asthma; sinus disease; drug allergy; and dermatologic allergy. He has had 15 articles, abstracts and/or letters accepted for publication and is a peer reviewer for Annals of Internal Medicine and Journal of Allergy & Clinical Immunology. National committee assignments include Vice Chair of the Asthma & Respiratory Disease Committee (American College of Allergy, Asthma & Immunology); and Asthma Diagnosis Committee; Rhinosinusitis Committee; and (Drug) Desensitization Task Force (American Academy of Allergy, Asthma & Immunology).

Dr. Feigenbaum has been featured on the air on Good Morning America, Sirius Radio, CBS News Radio, and the Rachael Ray Show, and has been quoted by NY Daily News and Los Angeles Times.

Dr. Feigenbaum is one of the few allergists in NYC to routinely perform aspirin desensitization, antibiotic desensitization, chemotherapy desensitization, and monoclonal desensitization.

Conditions treated in the office include allergic rhinitis and asthma; eczema/dermatitis; chronic cough; acute and chronic sinusitis; food allergy and eosinophilic esophagitis; aspirin exacerbated respiratory disease (AERD) and other allergic diseases. Office testing and procedures include skin testing for food and airborne allergies; patch testing for contact dermatitis; drug desensitization; and pulmonary function testing.

Insurance

AETNA HMO, AETNA INDEMNITY, AETNA MEDICARE, AETNA POS, AETNA PPO, Beech St PPO, Cigna HMO/POS, Cigna PPO, EBCBS EPO, EBCBS HLTHY NY, EBCBS HMO, EBCBS INDEMNITY, EBCBS MEDIBLUE, EBCBS POS, EBCBS PPO, GREATWEST PPO, HIP ACCESS I, HIP ACCESS II, HIP CHLD HLTH, HIP EPO/PPO, HIP HMO, HIP MEDICARE, HIP POS, LOCAL 1199 PPO, MULTIPLAN/PHCS PPO, NYS EMPIRE PLAN, OXFORD FREEDOM, Oxford Liberty, Oxford Medicare, UHC EPO, UHC HMO, UHC POS, UHC PPO, UHC TOP TIER, UPN Elite

Insurance Disclaimer: Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have changed.

« Back to Results [9]

Board Certification

2003 — Ab Allergy & Immunology (Clinical & Laboratory Immunology)

Education

1989 — Boston University Medical Center, Medical Education
1989-1990 — Mercy Hospital and Medical Center (Internal Medicine), Internship
1990-1992 — Mercy Hospital and Medical Center (Internal Medicine), Residency Training
1993-1995 — Mercy Hospital and Medical Center (Immunology & Allergy), Residency Training
1993-1995 — Scripps Memorial Hospital-La Jolla (Allergy), Clinical Fellowships

« Back to Results [9]

Research Interests

Dr. Feigenbaum is a Principal Investigator at NYU Langone, in a translational study relating to the etiology of chronic sinusitis; and in a study of knowledge of pulmonary function, anaphylaxis and radiocontrast media (RCM) allergy. He has a research interest in asthma, sinus disease and drug allergy and is a peer reviewer for the Annals of Internal Medicine and the Journal of Allergy & Clinical Immunology. He has published articles, abstracts or letters on: aspirin-sensitive asthma; reflux in asthma; bee sting allergy; vocal cord dysfunction; and nitric oxide in asthma.

Research Keywords

Asthma; "Food Allergy"; Hives; Allergy

« Back to Results [9]

All data from NYU Health Sciences Library Faculty Bibliography — -

Contact:
http://hsl.med.nyu.edu/faculty-bibliography-search [10]

Measurement of mycotoxins in patients with chronic rhinosinusitis
Lieberman S.M.; Jacobs J.B.; Lebowitz R.A.; Feigenbaum B.A.
2011 ;127(2 SUPPL 1):AB123-AB123, Journal of allergy & clinical immunology
— id: 127252, year: 2011, vol: 127, page: AB123, stat: Journal Article,

Measurement of Mycotoxins in Patients with Chronic Rhinosinusitis
Lieberman SM; Jacobs JB; Lebowitz RA; Fitzgerald MB; Crawford J; Feigenbaum BA
2011 Aug;145(2):327-329, Otolaryngology, head & neck surgery
— id: 137919, year: 2011, vol: 145, page: 327, stat: Journal Article,

Rapid desensitization did not prevent febrile idiosyncratic reactions to oxaliplatin
Mathew A.; Ballas M.S.; Gorsky M.; Feigenbaum B.A.
2011 ;127(2 SUPPL 1):AB195-AB195, Journal of allergy & clinical immunology
— id: 127253, year: 2011, vol: 127, page: AB195, stat: Journal Article,

Immediate hypersensitivity reaction and successful rapid desensitization to rituximab followed by serum sickness in a 4 year old
Romanos-Sirakis E.; Feigenbaum B.A.
2011 ;127(2 SUPPL 1):AB198-AB198, Journal of allergy & clinical immunology
— id: 127255, year: 2011, vol: 127, page: AB198, stat: Journal Article,

Special considerations for rapid drug desensitization with natalizumab
Sutaria M.; Miro K.; Mathew A.; Kister I.; Feigenbaum B.A.
2011 ;127(2 SUPPL 1):AB196-AB196, Journal of allergy & clinical immunology
— id: 127254, year: 2011, vol: 127, page: AB196, stat: Journal Article,

Iatrogenic Hypogammaglobulinemia Resembling Common Variable Immunodeficiency
Mathew A; Feigenbaum BA; Miro K; Weinfeld JN
2010 ;105:A101-A101, Annals of allergy, asthma & immunology
— id: 134324, year: 2010, vol: 105, page: A101, stat: Journal Article,

Successful Oxaliplatin Desensitization After Unsuccessful Infusion Using A Hypersensitivity Protocol
Miro K; Feigenbaum BA; Mathew A; Weinfeld JN
2010 ;105:A27-A27, Annals of all